Chlorozotocin
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C9H16ClN3O7 |
Molar mass | 313.69 g·mol−1 |
3D model (JSmol) | |
(what is this?) |
Chlorozotocin is a nitrosourea. It is used for cancer therapy.[citation needed]
The International Agency for Research on Cancer concluded it was "probably carcinogenic" in 1990[1]
It is an analogue of streptozotocin.[2]
References[]
- ^ Humans, IARC Working Group on the Evaluation of Carcinogenic Risk to (1990). SUMMARY OF FINAL EVALUATIONS. International Agency for Research on Cancer.
- ^ Wolfe MM (2006). Therapy of digestive disorders. Elsevier Health Sciences. p. 477. ISBN 978-1-4160-0317-5.
Categories:
- Drugs not assigned an ATC code
- Alkylating antineoplastic agents
- IARC Group 2A carcinogens
- Monosaccharide derivatives
- Nitrosoureas
- Chloroethyl compounds
- Antineoplastic and immunomodulating drug stubs